INS and type 2 diabetes mellitus: In October 2008, an independent international expert panel – comprising the authors o7f this report – met to review the current guidelines for insulin intensification therapy using BIAsp 30 in patients with type 2 diabetes, with the aim of developing international practical guidance for general and specialist practitioners.